Pharmacology, Toxicology and Pharmaceutical Science
Thymidylate Synthase
97%
Colorectal Cancer
74%
Colon Cancer
73%
Fluorouracil
73%
DNA
51%
Metastatic Colorectal Cancer
49%
Neoplasm
41%
Toxicity
37%
Epidermal Growth Factor Receptor
37%
Panobinostat
37%
Vorinostat
37%
Deoxyuridine Triphosphate Pyrophosphatase
35%
Deoxyuridine
35%
Histone Deacetylase Inhibitor
35%
Lapatinib
35%
Antitumor Activity
35%
Uracil
31%
Malignant Neoplasm
30%
Messenger RNA
29%
Irinotecan
29%
Oxaliplatin
29%
Interleukin 8
28%
Thymidine Phosphate
27%
Cancer Model
23%
Thymidine Triphosphate
22%
Survival
21%
Fluoropyrimidine
21%
Enzyme
21%
Diseases
20%
Chemotherapy
19%
Progression Free Survival
19%
Drug
19%
Thymidylate Synthase Inhibitor
19%
Histone
17%
Overall Survival
17%
Capecitabine
15%
Metastasis
15%
Receptor
15%
DNA Polymerase
14%
Non Small Cell Lung Cancer
14%
Stomach Cancer
13%
Chemokine Receptor CXCR2
13%
Malignant Neoplasm
13%
Lethality
12%
Protein
12%
SLCO1B1
11%
Vasculotropin Receptor
11%
Lymphedema
11%
Tumor Recurrence
11%
Plevitrexed
11%
Biochemistry, Genetics and Molecular Biology
Thymidylate Synthase
100%
Nested Gene
62%
Cancer Cell
61%
Uracil
60%
Deoxyuridine
59%
Colon
47%
Messenger RNA
46%
DNA
44%
Isoform
43%
Survival
40%
Gene Expression
40%
Protein
38%
Epidermal Growth Factor Receptor
35%
Angiogenesis
34%
Allele
33%
Fluorouracil
32%
Association
28%
Uracil-DNA Glycosylase
28%
Regulatory Mechanism
27%
Lysozyme
25%
Lapatinib
23%
Saccharomyces cerevisiae
23%
Antineoplastic Activity
23%
Vascular Endothelial Growth Factor
23%
Antifolate
22%
Anabolism
22%
Metabolic Pathway
22%
DNA Repair
20%
Interleukin 8
20%
Cytotoxicity
20%
Genotyping
19%
Time
19%
DNA Damage
19%
Consensus
18%
Phosphorylation
18%
Mutation
17%
Apoptosis
16%
Capecitabine
16%
N-Terminus
15%
Contrast
15%
Single-Nucleotide Polymorphism
15%
Kinase
15%
Genetic Marker
14%
Species
14%
Chemosensitivity
14%
Progression Free Survival
14%
Yeast
14%
Cyclooxygenase
14%
Overall Survival
13%
Gene Polymorphism
12%
Medicine and Dentistry
Patient
97%
Colorectal Cancer
74%
Fluorouracil
53%
Thymidylate Synthase
52%
Colon Cancer
50%
Therapeutic Procedure
46%
Epidermal Growth Factor Receptor
40%
Neoplasm
37%
Combination Therapy
37%
Chemotherapy
34%
Oxaliplatin
32%
Malignant Neoplasm
30%
Interleukin 8
30%
Inpatient
29%
Gene Expression
29%
Tissues
25%
Metastatic Colorectal Cancer
25%
Cancer Cell
24%
Lapatinib
23%
Histone Deacetylase Inhibitor
23%
Deoxyuridine Triphosphate Pyrophosphatase
23%
Cancer Model
23%
Antineoplastic Activity
23%
Diseases
20%
Metastatic Carcinoma
19%
Angiogenesis
19%
Overall Survival
18%
Gene
18%
Toxicity
17%
Association
17%
Progression Free Survival
17%
Survival
17%
Vasculotropin
16%
Messenger RNA
16%
Fluoropyrimidine
16%
Cells
16%
Molecular Marker
14%
Chemokine Receptor CXCR2
14%
Panobinostat
13%
Capecitabine
13%
Thymidylate Synthase Inhibitor
13%
Metabolism
13%
Thymidine Phosphate
13%
Targeted Therapy
13%
Tumor Progression
13%
Cyclooxygenase 2
13%
DNA
12%
Development
11%
Lymph Node
11%
Gender
11%
